The biological significance of FHIT protein expression in lung cancer and precancerous tissues detected by tissue microarray

Chinese Journal of Lung Cancer

Volumn 10, Issue 3, 2007, Pages 192-196

  Yuan, Ling ^a   Wang, Xinyun ^b   Zheng, Haiyan ^b  

^a TIANJIN MEDICAL UNIVERSITY   (China)

^b NONE

Author keywords

FHIT; Lung neoplasms; Precancerous lesion; Tissue microarray

Indexed keywords

FRAGILE HISTIDINE TRIAD PROTEIN;

ADULT; AGED; ARTICLE; CANCER GROWTH; CANCER STAGING; CARCINOGENESIS; FEMALE; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LUNG CANCER; LYMPH NODE METASTASIS; MALE; PRECANCER; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; SQUAMOUS CELL CARCINOMA; TISSUE MICROARRAY;

EID: 34347396638     PISSN: 10093419     EISSN: 19996187     Source Type: Journal    
DOI: None     Document Type: Article

References (13)

1. Wang XY, Zhu CZ, Liu T, et al. A study on manufacture of tissue microarray. J Tianjin Med Univ, 2005, 11(1): 24-35.
2. Ohta M, Inoue H, Cotticelli MG, et al. The FHIT gene, spanning the chromosome 3p14. 2 fragile site and renal carcinoma-associated t(3;8) breakpoint, is abnormal in digestive tract cancers. Cell, 1996, 84(4): 587-597.
3. Brambilla E, Travis WD, Colby TV, et al. The new World Health Organization classification of lung tumours. Eur Respir J, 2001, 18: 1059-1068.
4. Wang XY, Yao Z, Li Y, et al. Expression of survivin, PTEN and BFGF in lung cancer progression tissue microarray. Chin J Cancer Res, 2004, 16(4): 297-301.
5. Liu T, Wang XY, Zhu CZ, et al. Expression of KAI1 protein in tissue microarray and its biological significances in patients with lung cancer. Chin J Lung Cancer, 2005, 8(2): 116-119.
6. Lee CH, Lee MK, Kang CD, et al. Differential expression of hypoxia inducible factor-1 alpha and tumor cell proliferation between squamous cell carcinomas and adenocarcinomas among operable non-small cell lung carcinomas. J Korean Med Sci, 2003, 18(2): 196-203.
7. Sasaki H, Haneda H, Yukiue H, et al. Decreased fragile histidine triad gene messenger RNA expression in lung cancer. Clin Lung Cancer, 2006, 7(6): 412-416.
8. Tzao C, Tsai HY, Chen JT, et al. 5′ CpG island hypermethylation and aberrant transcript splicing both contribute to the inactivation of the FHIT gene in resected non-small cell lung cancer. Eur J Cancer, 2004, 40(14): 2175-2183. Erratum in: Eur J Cancer, 2005, 41(3): 478.
9. Rohr UP, Rehfeld N, Geddert H, et al. Prognostic relevance of fragile histidine triad protein expression in patients with small cell lung cancer. Clin Cancer Res, 2005, 11(1): 180-185.
10. Pavelic K, Krizanac S, Cacev T, et al. Aberration of FHIT gene is associated with increased tumor proliferation and decreased apoptosis-clinical evidence in lung and head and neck carcinomas. Mol Med, 2001, 7(7): 442-453.
11. Baffa R, Gomella LG, Vecchione A, et al. Loss of FHIT expression in transitional cell carcinoma of the urinary bladder. Am J Pathol, 2000, 156(2): 419-424.
12. Toledo G, Sola JJ, Lozano MD, et al. Loss of FHIT protein expression is related to high proliferation, low apoptosis and worse prognosis in non-small-cell lung cancer. Mod Pathol, 2004, 17(4): 440-448.
13. de Fraipont F, Moro-Sibilot D, Michelland, et al. Promoter methylation of genes in bronchial lavages: a marker for early diagnosis of primary and realpsing non-small cell lung cancer? Lung Cancer. 2005, 50(2): 199-209.